Ulrik Talleruphuus

Ulrik Talleruphuus

Auto-generated profile, based on publicly available information

Ulrik Talleruphuus

Department of Clinical Physiology and Nuclear Medicine (U.T., L.M., N.W., K.G.), Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
SHSigne Højstrup
Signe Højstrup
KHKim W. Hansen
Kim W. Hansen
UTUlrik Talleruphuus
Ulrik Talleruphuus
LMLisbeth Marner
Lisbeth Marner
LBLouise Bjerking
Louise Bjerking
EPEva Prescott
Eva Prescott
BACKGROUND: Rubidium-82 positron emission tomography ( 82 Rb PET) myocardial perfusion imaging is used in clinical practice to quantify regional perfusion defects. Additionally, 82 Rb PET provides a measure of absolute myocardial flow reserve (MFR), describing the vasculature state of health. We assessed whether 82 Rb PET-derived MFR is associated with all-cause mortality independently of the extent of perfusion defects. METHODS: We conducted a multicenter clinical registry-based study of patients undergoing 82 Rb PET myocardial perfusion imaging on suspicion of chronic coronary syndromes. Patients were followed up in national registries for the primary outcome of all-cause mortality. Global MFR ≤2 was considered reduced. RESULTS: Among 7169 patients studied, 38.1% were women, the median age was 69 (IQR, 61–76) years, and 39.0% had MFR ≤2. A total of 667 (9.3%) patients died during a median follow-up of 3.1 (IQR, 2.6–4.0) years, more in patients with MFR ≤2 versus MFR >2 (15.7% versus 5.2%; P <0.001). MFR ≤2 was associated with all-cause mortality across subgroups defined by the extent of perfusion defects (all P <0.05). In a Cox survival regression model adjusting for sex, age, comorbidities, kidney function, left ventricular ejection fraction, and perfusion defects, MFR ≤2 was a robust predictor of mortality with a hazard ratio of 1.62 (95% CI, 1.31–2.02; P <0.001). Among patients with no reversible perfusion defects (n=3101), MFR ≤2 remained strongly associated with mortality (hazard ratio, 1.86 [95% CI, 1.26–2.73]; P <0.01). The prognostic value of impaired MFR was similar for cardiac and noncardiac death. CONCLUSIONS: MFR ≤2 predicts all-cause mortality independently of the extent of perfusion defects. Our results support the inclusion of MFR when assessing the prognosis of patients suspected of chronic coronary syndromes.

20 June 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
SHSigne Højstrup
Signe Højstrup
KHKim W. Hansen
Kim W. Hansen
UTUlrik Talleruphuus
Ulrik Talleruphuus
LMLisbeth Marner
Lisbeth Marner
SGSøren Galatius
Søren Galatius
EPEva I. B. Prescott
Eva I. B. Prescott
Background: Coronary microvascular disease (CMD) may be part of a systemic small vessel disease that also manifests as neurological impairment and kidney disease. However, clinical evidence supporting a potential link is scarce. We assessed whether CMD is associated with an increased risk of small vessel disease in the kidney and brain. Methods and Results: A retrospective multicenter (n=3) study of patients clinically referred to 82‐rubidium positron emission tomography myocardial perfusion imaging was conducted between January 2018 and August 2020. Exclusion criterion was reversible perfusion defects >5%. CMD was defined as myocardial flow reserve (MFR) ≤2. The primary outcome, microvascular event, was defined by hospital contact for chronic kidney disease, stroke, or dementia. Among 5122 patients, 51.7% were men, median age 69.0 [interquartile range, 60.0–75.0] years, 11.0% had left ventricular ejection fraction ≤40%, and 32.4% had MFR ≤2. MFR was associated with baseline estimated glomerular filtration rate after multivariable adjustment ( β =0.04 [95% CI, 0.03–0.05]; P 2 (11.6% versus 5.5%, P <0.001). MFR ≤2 was associated to outcome with a hazard ratio (HR) of 2.30 (95% CI, 1.88–2.81, P <0.001) and an adjusted HR of 1.62 (95% CI, 1.32–2.00, P <0.001). Results were consistent across subgroups defined by presence of irreversible perfusion defects, estimated glomerular filtration rate, diabetes, left ventricular ejection fraction, and previous revascularization. Conclusions: This is the first large‐scale cohort study to link CMD to microvascular events in the kidney and brain. Data support the hypothesis that CMD is part of a systemic vascular disorder.

1 January 2006 in Blood Pressure
Verified
Journal Article
Closed access
UTUlrik Talleruphuus
Ulrik Talleruphuus
LBLia Evi Bang
Lia Evi Bang
NWNiels Wiinberg
Niels Wiinberg
JMJesper Mehlsen
Jesper Mehlsen
TSTage Lysbo Svendsen
Tage Lysbo Svendsen
MBMichael Weis Bentzon
Michael Weis Bentzon
Isolated systolic hypertension (ISH) is a major risk factor for cardiovascular complications. Nevertheless, data on the prevalence in a representative population do not seem to be available. The prevalence of ISH and the white coat effect was thus studied in a cross-sectional survey of 2806 inhabitants aged 70-80 years. In untreated subjects, the prevalence of ISH was 17.4% (95% CI 14.9-20.2) in women and 13.5% (95% CI 11.3-15.9) in men using clinic blood pressure at first visit. The prevalence increased significantly with age. The prevalence was reduced to 10.4% when using the average of all-visits clinic blood pressures. By a simulation model, it was demonstrated that his reduction mainly resulted from a regression towards the mean. Average all-visits clinic blood pressure was 172.6 +/- 10.4/81.1 +/- 6.0 mmHg. Less than one-third of those with all-visit ISH had sustained ISH. Identifying subjects with sustained ISH requires measurements in more than three visits.

16 February 2009
Verified
Journal Article
Closed access
NRNatasha Roseva-Nielsen
Natasha Roseva-Nielsen
KKKjeld Kristensen
Kjeld Kristensen
UTUlrik Talleruphuus
Ulrik Talleruphuus
TSTage Lysbo Svendsen
Tage Lysbo Svendsen